AlzChem Group AG
ACT.XETRA
| Exchange: | XETRA |
| Currency | Euro |
| ISIN: | DE000A2YNT30 |
| LEI: | 8945004EL7WZK3ERG181 |
| Primary Ticker: | ACT.XETRA |
| Fiscal Year End: | December |
| Sector: | Basic Materials |
| Industry: | Specialty Chemicals |
| Gic Sector: | Materials |
| Gic Group: | Materials |
| Gic Industry: | Chemicals |
| Gic Sub Industry: | Specialty Chemicals |
| Description: | Alz Chem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. The company was founded in 1908 and is based in Trostberg, Germany. |
| Address: | Dr.-Albert-Frank-Strasse 32, Trostberg, Germany, 83308 |
| Website: | https://www.alzchem.com |
| Full Time Employees: | 1506 |
| Updated On: | 2024-11-03 |
Highlights
| Market Capitalization: | 529167616 |
| Market Capitalization Mln: | 529.16 |
| EBITDA: | 90382000 |
| PE Ratio: | 11.42 |
| Wall Street Target Price: | 26.05 |
| Book Value: | 17.74 |
| Dividend Share: | 1.2 |
| Dividend Yield: | 0.02 |
| Earnings Share: | 4.55 |
| EPS Estimate Current Year: | 2.5 |
| EPS Estimate Next Year: | 1.87 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.08 |
| Operating Margin TTM: | 0.14 |
| Return On Assets TTM: | 0.09 |
| Return On Equity TTM: | 0.28 |
| Revenue TTM: | 556768000 |
| Revenue Per Share TTM: | 54.71 |
| Quarterly Revenue Growth YOY: | 0.08 |
| Gross Profit TTM: | 270267000 |
| Diluted Eps TTM: | 4.55 |
| Quarterly Earnings Growth YOY: | 0.99 |
Valuation
| Trailing PE: | 11.42 |
| Forward PE: | 9.54 |
| Price Sales TTM: | 0.95 |
| Price Book MRQ: | 2.94 |
| Enterprise Value: | 543207687 |
| Enterprise Value Revenue: | 0.98 |
| Enterprise Value Ebitda: | 5.55 |
Shares
| Shares Outstanding: | 10176300 |
| Shares Float: | 5008589 |
| Percent Insiders: | 49.65 |
| Percent Institutions: | 18.58 |
Technicals
| Beta: | 1.00 |
| 52 Week High: | 61.8 |
| 52 Week Low: | 20.91 |
| 50 Day MA: | 49.71 |
| 200 Day MA: | 42.78 |
Splits & Dividends
| Forward Annual Dividend Rate: | 1.2 |
| Forward Annual Dividend Yield: | 0.02 |
| Payout Ratio: | 0.26 |
| Ex Dividend Date: | 2024-05-08 |
| Last Split Factor: | 1:10 |
| Last Split Date: | 2019-07-01 |
Earnings
| Report Date: | 2025-07-30 |
| Date: | 2025-06-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2025-04-30 |
| Date: | 2025-03-31 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2025-02-27 |
| Date: | 2024-12-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2024-11-07 |
| Date: | 2024-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2024-08-01 |
| Date: | 2024-06-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2023-10-26 |
| Date: | 2023-09-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2022-10-26 |
| Date: | 2022-09-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | 0.59 |
| Eps Estimate: | 0.35 |
| Eps Difference: | 0.24 |
| Surprise Percent: | 68.57 |
| Report Date: | 2018-05-15 |
| Date: | 2018-03-31 |
| Currency: | EUR |
| Eps Actual: | 0.77 |
| Report Date: | 2018-03-26 |
| Date: | 2017-12-31 |
| Currency: | EUR |
| Eps Actual: | 0.15 |
| Report Date: | 2017-11-24 |
| Date: | 2017-09-30 |
| Currency: | EUR |
| Eps Actual: | 3.94 |
| Date: | 2023-12-31 |
| Period: | +1y |
| Growth: | -0.25 |
| Earnings Estimate Avg: | 1.87 |
| Earnings Estimate Low: | 1.23 |
| Earnings Estimate High: | 2.98 |
| Earnings Estimate Year Ago Eps: | 2.50 |
| Earnings Estimate Number Of Analysts: | 3.00 |
| Earnings Estimate Growth: | -0.25 |
| Revenue Estimate Avg: | 592830000.00 |
| Revenue Estimate Low: | 534300000.00 |
| Revenue Estimate High: | 676500000.00 |
| Revenue Estimate Number Of Analysts: | 3.00 |
| Revenue Estimate Growth: | 0.12 |
| Eps Trend Current: | 1.87 |
| Eps Trend7days Ago: | 1.87 |
| Eps Trend30days Ago: | 2.31 |
| Eps Trend60days Ago: | 2.66 |
| Eps Trend90days Ago: | 2.98 |
| Date: | 2023-03-31 |
| Period: | +1q |
| Date: | 2022-12-31 |
| Growth: | -0.08 |
| Earnings Estimate Avg: | 2.50 |
| Earnings Estimate Low: | 2.29 |
| Earnings Estimate High: | 2.81 |
| Earnings Estimate Year Ago Eps: | 2.72 |
| Earnings Estimate Number Of Analysts: | 4.00 |
| Earnings Estimate Growth: | -0.08 |
| Revenue Estimate Avg: | 526770000.00 |
| Revenue Estimate Low: | 516700000.00 |
| Revenue Estimate High: | 534100000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 0.24 |
| Eps Trend Current: | 2.50 |
| Eps Trend7days Ago: | 2.57 |
| Eps Trend30days Ago: | 2.66 |
| Eps Trend60days Ago: | 2.79 |
| Eps Trend90days Ago: | 2.60 |
| Eps Revisions Up Last30days: | 1.00 |
| Eps Revisions Down Last30days: | 1.00 |
| Date: | 2022-09-30 |
| Earnings Estimate Avg: | 0.35 |
| Earnings Estimate Low: | 0.35 |
| Earnings Estimate High: | 0.35 |
| Earnings Estimate Number Of Analysts: | 1.00 |
| Revenue Estimate Avg: | 117300000.00 |
| Revenue Estimate Low: | 116000000.00 |
| Revenue Estimate High: | 118610000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 0.22 |
| Eps Trend Current: | 0.35 |
| Eps Trend7days Ago: | 0.35 |
| Date: | 2022-06-30 |
| Revenue Estimate Avg: | 128000000.00 |
| Revenue Estimate Low: | 128000000.00 |
| Revenue Estimate High: | 128000000.00 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Revenue Estimate Growth: | 0.33 |
| Date: | 2022-03-31 |
| Date: | 2021-12-31 |
| Revenue Estimate Avg: | 464220000.00 |
| Revenue Estimate Low: | 436200000.00 |
| Revenue Estimate High: | 480700000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 0.09 |
| Date: | 2024-09-30 |
| Eps Actual: | 1.36 |
| Date: | 2017-12-31 |
| Eps Actual: | 4.09 |